Enzyme Replacement Therapy Market Set to Reach USD 10,707.6 Million by 2024 at a 6.60% of CAGR

Enzyme Replacement Therapy Market

Enzyme Replacement Therapy Market

The global enzyme replacement therapy (ERT) market is expected to achieve a valuation of USD 10,707.6 million by 2024, driven by the increasing prevalence of lysosomal storage diseases (LSDs) and advancements in healthcare infrastructure. Medical studies indicate that one in every 7,000 childbirths is affected by lysosomal storage disease, a figure that is anticipated to rise, particularly in underdeveloped regions with limited awareness and healthcare access.

ERT plays a crucial role in treating rare genetic disorders, including Gaucher disease and Fabry disease, offering hope for patients affected by these conditions. The growing application of ERT, along with improvements in medical technology and the availability of modern healthcare facilities, has contributed to the market’s expansion.

Government initiatives to increase public awareness and lenient reimbursement policies are also driving market growth. By the end of the forecast period, the market is projected to reach a valuation of USD 20,289.1 million.

Enzyme Replacement Therapy Industry: Regional Insights

With nearly 25%-30% market share, North America dominated the Global Enzyme Replacement Therapy Industry in 2017, partly due to the presence of leading market players in the region. In developing regions such as Latin America, advancements in medical facilities are helping the region cope with the healthcare crisis. Medical facilities in Brazil are equivalent to hospitals in the United States, with some even exceeding American standards. Brazil offers everything from large, full-service hospitals to smaller, intimate private clinics.

Brazil has developed into a center of excellence for healthcare in Latin America, with major universities that support the research, teaching, and training of medical professionals. Western Europe is the second largest market globally and is expected to be valued at US$ 2,893.2 Mn by 2028, with France, Italy, and Spain projected to witness significant growth rates. Japan is expected to be the third largest market for enzyme replacement therapy.

Enzyme Replacement Therapy Market: Segmentation & Forecast

The Global Enzyme Replacement Therapy Industry has been segmented based on therapeutic condition, route of administration, distribution channel, and region. Therapeutic conditions in the enzyme replacement therapy markets include Fabry disease, Gaucher disease, mucopolysaccharidosisPompe disease, lysosomal acid lipase deficiency, and others.

Globally, the mucopolysaccharidosis therapeutic condition is the most attractive segment. The injectable segment remains the most lucrative route of administration in the Global Enzyme Replacement Therapy Industry. Among all distribution channels for enzyme replacement therapy, specialty treatment pharmacies are expected to be the most lucrative, followed by hospital pharmacies.

Key Research Findings

Enzyme replacement therapy is used in the treatment of rare diseases and the global market is projected to create incremental opportunity of US$ 6,448.3 Mn between 2022 and 2028

When compared to other established markets such as North America, the enzyme replacement therapy markets in Japan and Western Europe are expected to witness fast and steady growth, partly due to the increasing governmental support and growing demand for enzyme replacement therapy for the treatment of rare diseases.

Enzyme Replacement Therapy Market: Competitive Landscape

  • Sanofi S.A. (Genzyme Corporation)
  • Shire plc.
  • Pfizer Inc.
  • Alexion Pharmaceuticals Inc.
  • BioMarin Pharmaceutical Inc.
  • Ultragenyx Pharmaceutical Inc.
  • Johnson & Johnson Services Inc.
  • Allergan plc.
  • Leadiant Biosciences Inc.

Pompe Disease Treatment Market Is a type of treatment for certain genetic diseases that are caused by a deficiency in a specific enzyme. This therapy involves administering the missing enzyme to the patient, usually through intravenous infusion.

A Old Full  Report Analysis Click Here 

Key Segments of Enzyme Replacement Therapy Industry Survey

by Therapeutic Condition:

  • Enzyme Replacement Therapy for Fabry Disease
  • Enzyme Replacement Therapy for Gaucher Disease
  • Enzyme Replacement Therapy for Mucopolysaccharidosis
    • MPS I
    • MPS II (Hunter Syndrome)
    • MPS IVA (Morquio Syndrome, Type A)
    • MPS VI (Maroteaux-Lamy Syndrome)
    • MPS VII (Sly Syndrome)
  • Enzyme Replacement Therapy for Pompe Disease
  • Enzyme Replacement Therapy for Lysosomal Acid Lipase Deficiency
  • Others

by Route of Administration:

  • Oral Enzyme Replacement Therapy
  • Injectable Enzyme Replacement Therapy

by Distribution Channel:

  • Hospital Pharmacies
  • Specialty Treatment Pharmacies
  • Retail Pharmacies

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges clients face and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

Matched content

Editor’s pick

Express Press Release Distribution